News

The Latest Industry News

How ChatGPT helped one patient correct his diabetes misdiagnosis

Posted on February 29, 2024

Artificial Intelligence (AI) is infiltrating everything these days, even medical diagnoses. One young patient of ours was misdiagnosed with Type 1 diabetes (T1D), but through his own intuition, research using ChatGPT, and the help of Dr. Keta Pandit, discovered that he had an inherited form of diabetes known as Maturity-Onset Diabetes of the Young (MODY). 24-year-old […]

Read More
hyperparathyroidism

What is Hyperparathyroidism?

Posted on February 15, 2024

At Texas Diabetes & Endocrinology, our board-certified endocrinology experts treat a number of endocrinological conditions including diabetes and thyroid disease. We also treat some less common hormone-related conditions such as hyperparathyroidism causing hypercalcemia. What is hypercalcemia? Hypercalcemia is caused by above normal calcium levels in your blood. Excess calcium in the blood can lead to weakened bones or osteoporosis, kidney stones or kidney […]

Read More
GLP-1RA gastrointestinal side effects

What are the GI side effects of GLP-1RA Medications, like Ozempic?

Posted on February 9, 2024

In treating T2D diabetes patients, our Texas Diabetes & Endocrinology board-certified experts may recommend medication to help lower blood sugars in addition to lifestyle changes. Some injectable forms of medical therapy, known as GLP-1RA medications, have been trending in the news lately due to their role in weight-loss management.  These drugs go by popular brand names such as Ozempic, Mounjaro, and Trulicity.  While […]

Read More
Texas Diabetes first to offer new treatment to delay stages of T1D

Texas Diabetes First to Offer New Treatment to Delay Stages of T1D

Posted on January 24, 2024

At Texas Diabetes & Endocrinology, we take pride in offering the most innovative treatments and top clinical trials for conditions affecting the endocrine system, like diabetes. Recently one of our patients, Liberty, became the first person in Central Texas to try a new drug, TZIELD, to delay the onset of stage 3 type 1 diabetes (T1D). TZIELD is an infusion-based treatment that […]

Read More